WEALTH ENHANCEMENT ADVISORY SERVICES, LLC - MIRUM PHARMACEUTICALS INC ownership

MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 162 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.

Quarter-by-quarter ownership
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC ownership history of MIRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$561,024
-29.1%
16,409
-47.9%
0.00%
-50.0%
Q1 2024$791,004
-17.2%
31,489
-2.7%
0.00%
-33.3%
Q4 2023$955,002
-6.6%
32,351
+0.0%
0.00%0.0%
Q3 2023$1,022,19732,3480.00%
Other shareholders
MIRUM PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 6,495,392$222,077,45210.39%
BOONE CAPITAL MANAGEMENT LLC 523,679$17,904,5854.67%
TANG CAPITAL MANAGEMENT LLC 1,287,107$44,006,1884.48%
BVF INC/IL 4,370,024$149,411,1214.19%
First Turn Management, LLC 703,398$24,049,1783.91%
Nan Fung Group Holdings Ltd 106,100$3,627,5593.87%
Prosight Management, LP 314,800$10,763,0123.22%
Novo Holdings A/S 1,500,000$51,285,0002.98%
Lion Point Capital, LP 45,000$1,538,5502.80%
Highlander Partners, L.P. 122,980$4,204,6862.80%
View complete list of MIRUM PHARMACEUTICALS INC shareholders